Clinical trial
Development of New Multi-contrasts Approaches by Magnetic Resonance Imaging at 3 Tesla Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients.
NCT02800460 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of New Multi-contrasts Approaches by Magnetic Resonance Imaging at 3 Tesla Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients.
- Lead sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 12, 2016
- Completion date
- November 9, 2025
- Enrollment
- 105 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.